Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Mandatory HPV Vaccination and Political Debate

Mandatory HPV Vaccination and Political Debate COMMENTARY ONLINE FIRST Mandatory HPV Vaccination and Political Debate to 24 years (44.8% for ages 20-24 years), followed by a Lawrence O. Gostin, JD gradual decline through age 59 years; high-risk HPV types are detected in only 3.4% of women tested. ACCINATIONS ARE AMONG THE MOST COST- Nononcogenic HPV types 6 and 11 are associated with effective and widely used public health interven- genital warts and recurrent respiratory papillomatosis. High- tions but have provoked popular resistance, with risk HPV types are detected in virtually all cervical, vagi- Vcompulsory vaccination framed as an unwarranted nal, and vulvar cancers in women, and HPV types 16 and state interference. When the US Food and Drug Administra- 18 are associated with 70% of cervical cancers. Each year, tion (FDA) approved a human papillomavirus (HPV) vac- more than 12 000 new cervical cancer cases are diagnosed cine in 2006, conservative religious groups strongly opposed in the United States, with more than 4000 deaths from cer- a mandate, arguing it would condone premarital sex and un- vical cancer occurring annually. Human papillomavirus also dermine parental rights. Yet Governor Rick Perry signed an is associated with cancer of the penis, as well as cancers of executive http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Mandatory HPV Vaccination and Political Debate

JAMA , Volume 306 (15) – Oct 19, 2011

Loading next page...
 
/lp/american-medical-association/mandatory-hpv-vaccination-and-political-debate-ZPJykQZwXS

References (12)

Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2011.1525
pmid
21979129
Publisher site
See Article on Publisher Site

Abstract

COMMENTARY ONLINE FIRST Mandatory HPV Vaccination and Political Debate to 24 years (44.8% for ages 20-24 years), followed by a Lawrence O. Gostin, JD gradual decline through age 59 years; high-risk HPV types are detected in only 3.4% of women tested. ACCINATIONS ARE AMONG THE MOST COST- Nononcogenic HPV types 6 and 11 are associated with effective and widely used public health interven- genital warts and recurrent respiratory papillomatosis. High- tions but have provoked popular resistance, with risk HPV types are detected in virtually all cervical, vagi- Vcompulsory vaccination framed as an unwarranted nal, and vulvar cancers in women, and HPV types 16 and state interference. When the US Food and Drug Administra- 18 are associated with 70% of cervical cancers. Each year, tion (FDA) approved a human papillomavirus (HPV) vac- more than 12 000 new cervical cancer cases are diagnosed cine in 2006, conservative religious groups strongly opposed in the United States, with more than 4000 deaths from cer- a mandate, arguing it would condone premarital sex and un- vical cancer occurring annually. Human papillomavirus also dermine parental rights. Yet Governor Rick Perry signed an is associated with cancer of the penis, as well as cancers of executive

Journal

JAMAAmerican Medical Association

Published: Oct 19, 2011

There are no references for this article.